Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Adrian Casty"'
Autor:
Antonello Calderoni, Seong-Jang Kim, Xiangdong Li, Lukas C. Heukamp, Salah-Eddin Al-Batran, Rudolf Morant, Yuan Guo, Uwe Pinkert, Stefan Aebi, Adrian Casty, Christoph Springfeld, Daniel Betticher, Arndt Vogel, Katharina König, R. R. Plentz, Chaoyang Cui, Carola Stadelmann, Martina Becker-Schiebe, Oliver Gautschi, Christa Baumann, Andreas Trojan, Christoph Mamot, Erica Pellicioli, Matthias Sperling, Franziska Aebersold-Keller, Wolfgang Hoffmann, Giannicola DʼAddario, Samuel Chang, Volker Kunzmann, Frank Kullmann, Reinhard Büttner, Jens T. Siveke, Guang Yang, Sonja Jehle-Schwertfeger, Joachim Diebold, Katharina Buser, Helmut Oettle, Claudius Irlé, Hanno Riess
Publikováno v:
Oncology Research and Treatment. 38:553-558
Autor:
Jens T. Siveke, Christoph Mamot, Lukas C. Heukamp, Erica Pellicioli, Uwe Pinkert, Joachim Diebold, Salah-Eddin Al-Batran, Chaoyang Cui, Oliver Gautschi, Frank Kullmann, Hanno Riess, Giannicola DʼAddario, Antonello Calderoni, Carola Stadelmann, Daniel Betticher, Wolfgang Hoffmann, Yuan Guo, Reinhard Büttner, Christa Baumann, Helmut Oettle, Guang Yang, Franziska Aebersold-Keller, Stefan Aebi, Xiangdong Li, Claudius Irlé, R. R. Plentz, Arndt Vogel, Volker Kunzmann, Katharina Buser, Katharina König, Rudolf Morant, Andreas Trojan, Sonja Jehle-Schwertfeger, Christoph Springfeld, Samuel Chang, Adrian Casty, Seong-Jang Kim, Martina Becker-Schiebe, Matthias Sperling
Publikováno v:
Oncology Research and Treatment. 38:I-VI
Autor:
Katharina Buser, Giannicola DʼAddario, Erica Pellicioli, R. Morant, Lukas C. Heukamp, Franziska Aebersold-Keller, Joachim Diebold, Christa Baumann, Andreas Trojan, Christoph Mamot, Carola Stadelmann, Sonja Jehle-Schwertfeger, Oliver Gautschi, Katharina König, Antonello Calderoni, Daniel Betticher, Reinhard Büttner, Stefan Aebi, Claudius Irlé, Adrian Casty
Publikováno v:
Oncology research and treatment. 38(11)
Background: The role of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) in the treatment of patients with advanced non-small cell lung cancer (NSCLC) and unknown EGFR mutation status has recently been questioned. Patients and
Autor:
Sherif I. Assaad, Simon N. Powell, Khaled Attia, Peryhan Molokhia, Marek Ancukiewicz, Rita F. Abi-Raad, Adrian Casty, Alphonse G. Taghian, Timothy Sullivan, Yves Boucher, Eren D. Yeh, Irene Kuter
Publikováno v:
Journal of Clinical Oncology. 23:1951-1961
Purpose It has been hypothesized that tumors with high interstitial fluid pressure (IFP) and/or hypoxia respond poorly to chemotherapy (CT) because of poor drug delivery. Preclinical studies have shown that paclitaxel reduces the IFP and improves the